Wine polyphenols and protection from atherosclerosis and ischemic heart disease: Drink to your health?

Phytochemicals in Nutrition and Health

Volumn , Issue , 2002, Pages 41-60

  Dubick, Michael A ^a,b  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875564541     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (127)

1. Abu-Amsha, R., Croft, K.D., Puddey, I.B., Proudfoot, J.M., and Beilin, L.J. 1996. Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: identification and mechanism of action of some cinnamic acid derivatives from red wine, Clin. Sci., 91:449–458.
2. Andriambeloson, E., Kleschyov, A.L., Muller, B., Beretz, A., Stoclet, J.C., and Andriantsitohania, R. 1997. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta, Brit. J. Pharmacol., 120:1053–1058.
3. Andriambeloson, E., Magnier, C., Haan-Archipoff, G., Lobstein, A., Anton, R., Beretz, A., Stoclet, J.C., and Andriantsitohaina, R. 1998. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta, J. Nutr., 128:2324–2333.
4. Arai, Y., Wantanabe, S., Kimira, M., Shimoi, K., Mochizuki, R., and Kinae, N. 2000. Dietary intake of flavonoids, flavones, and isoflavones by Japanese women and the inverse correlation between Quercetin intake and plasma LDL cholesterol concentration, J. Nutr., 130:2243–2250.
5. Arizza, R.R. and Pueyo, C. 1991. The involvement of reactive oxygen species in the direct acting mutagencity of wine, Mutat. Res., 251:115–121.
6. Aviram, M. and Fuhrman, B. 1998. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis, Atherosclerosis, 13:S45–S50.
7. Bell, J.R.C., Donovan, J.L., Wong, R., Waterhouse, A.L., German, J.B., Walzem, R.L., and Kasim-Karakas, S.E. 2000. Catechin in human plasma after ingestion of a single serving of reconstituted red wine, Am. J. Clin. Nutr., 71:103–108.
8. Bravo, L. 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance, Nutr. Rev., 56:317–333.
9. Brouillard, R., George, F., and Fougerousse, A. 1997. Polyphenols produced during red wine ageing, Biofactors, 6:403–410.
10. Burkitt, M.J. and Duncan, J. 2000. Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action, Arch. Biochem. Biophys., 381:253–263.
11. Burr, M.L. 1999. Explaining the French paradox, J. R. Soc. Health, 115:217–219.
12. Caccetta, R.A.-A., Croft, K.D., Beilin, L.J., and Puddey, I.B. 2000. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability, Am. J. Clin. Nutr., 71:67–74.
13. Caldu, P., Hurtado, I., and Fiol, C. 1996. White wine reduces the susceptibility of low-density lipoprotein to oxidation, Am. J. Clin. Nutr., 63:403.
14. Campos, A.M. and Lissi, E.A. 1996. Total antioxidant potential of Chilean wines, Nutr. Res., 16:385–389.
15. Canali, R., Vignolini, F., Nobili, F., and Mengheri, E. 2000. Reduction of oxidative stress and cytokine-induced neutrophil chemoattractant (CINC) expression by red wine polyphenols in zinc deficiency intestinal damage of rat, Free Rad. Biol. Med., 28:1661–1670.
16. Cao, G., Russell, R.M., Lischner, N., and Prior, R.L. 1998. Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women, J. Nutr., 128:2383–2390.
17. Cao, G., Sofic, E., and Prior, C. 1997. Antioxidant and pro-oxidant behavior of flavonoids: structure–activity relationships, Free Rad. Biol. Med., 22:749–760.
18. Cestaro, B., Simonetti, P., Cervato, G., Brusamolino, A., Gatti, P., and Testolin, G. 1996. Red wine effects on peroxidation indexes of rat plasma and erythrocytes, in J. Food. Sci. Nutr., 47:181–189.
19. Chan, P.T., Fong, W.P., Cheung, Y.L., Huang, Y., Ho, W.K., and Chen, Z.Y. 1999. Jasmine green tea epicatechins are hypolipidemic in hamsters (MesocritcetusAuratus) fed a high-fat diet, J. Nutr., 129:1094–1101.
20. Chun, Y.J., Kim, M.Y., and Guengerich, F.P. 1999. Resveratrol is a selective human cytochrome P450 1A1 inhibitor, Biochem. Biophys. Res. Commun., 262:20–25.
21. Cleophas, T.J., Tuinenberg, E., Van Der Meulen, J., and Zwinderman, K.H. 1996. Wine consumption and other dietary variables in males under 60 before and after acute myocardial infarction, Angiology, 47:789–796.
22. Clifford, A.J., Ebeler, J.D., Bills, N.D., Hinrichs, S.H., Teissedre, P.L., Waterhouse, A.L. 1996. Delayed tumor onset in transgenic mice fed an amino acid-based diet supplement with red wine solids, Am. J. Clin. Nutr., 64:748–756.
23. Clydesdale, F.M. (ed). 1999. Epigallocatechin and epigallocatechin-3-gallate, Crit. Rev. Food Sci. Nutr., 39:215–226.
24. Conquer, J.A., Miaani, G., Azzini, E., Raguzzini, A., Holub, B.J. 1998. Supplementation with Quercetin markedly increases plasma Quercetin concentration without effect on selected risk factors for heart disease in healthy subjects, J. Nutr., 128:593–597.
25. Constant, J. 1997. Alcohol, ischemic heart disease, and the French Paradox, Clin. Cardiol., 20:420–424.
26. Criqui, M.H. and Ringel, B.L. 1994. Does diet or alcohol explain the French Paradox, Lancet, 34:1719–1723.
27. Croft, K.D. 1998. The chemistry and biological effects of flavonoids and phenolic acids, Ann. N.Y. Acad. Sci., 854:435–442.
28. Das, D.K., Sato, M., Ray, P.S., Maulik, G., Engelman, R.M., and Bertelli, A.A. 1999. Cardioprotection of red wine: role of polyphenolic antioxidants, Drugs Exp. Clin. Res., 25:115–120.
29. Day, A. and Stansbie, D. 1995. Cardioprotective effect of red wine may be by urate, Clin. Chem., 41:1319–1320.
30. Decker, E.A. 1997. Phenolics: pro-oxidants or antioxidants, Nutr. Rev., 55:396–398.
31. Demrow, H.S., Slane, P.R., and Folts, J.D. 1995. Administration of wine and grape juice inhibits in vivo patients’ activity and thrombosis in stenosed canine arteries, Circulation, 91:1182–1188.
32. De Rijke, Y.B., Demacker, P., Assen, N.A., Sloots, L.M., Katan, M.B., and Stalenhoef, A.F.H. 1996. Red wine consumption does not effect oxidizabilitiy of low-density lipoproteins in volunteers, Am. J. Clin. Nutr., 63:329–334.
33. de Vries, J.H.M., Hollman, P.C.H., Meyboom, S., Buysman, M.N.C.P., Zock, P.L., van Staveren, W.A., and Katan, M.B. 1998. Plasma concentrations and urinary excretion of the antioxidant flavonols Quercetin and Kaempferol as biomarkers for dietary intake, Am. J. Clin. Nutr., 68:60–65.
34. Dresoti, I.E. 1996. Bioactive ingredients: antioxidants and polyphenols in tea, Nut. Rev., 54:S51–S58.
35. Dresoti, I.E. 2000. Antioxidant polyphenols in tea, cocoa, and wine, Nutr., 16:692–694.
36. Drewnoswski, A., Henderson, S.A., and Shore, A.B., et al. 1996. Diet quality and dietary diversity in France: implications for the French Paradox, J. Am. Diet Assoc., 96:663–669.
37. Dubick, M.A., Hunter, G.C., and Keen, C.L. 1991. Trace element and mineral concentrations in serum and aorta from patients with abdominal aneurysmal or occlusive disease, J. Trace Elem. Exp. Med., 4:173–182.
38. Dubick, M.A. and Omaye, S.T. 2001. Modification of atherogensis and heart disease by grape wine and tea polyphenols, in Handbook of Nutraceuticals and Functional Foods (Wildman REC, ed.), CRC Press, Boca Raton, FL, pp. 235–260.
39. Dufour, M.C. and Fe Caces, M. 1993. Epidemiology of the medical consequences of alcohol, Alcohol Health Res. Wld., 17:265–271.
40. Durak, I., Koseoglu, M.H., Kacmaz, M., Buyukkocak, S., Cimen, B., and Ozturk, H.S. 1999. Black grape enhances plasma antioxidant potential, Nutr. Res., 19:973–977.
41. Falcao, J.M., Dias, J.A., Miranda, A.C., Leitao, C.N., Lacerda, M.M., and da Motta, L.C. 1994. Red wine consumption and gastric cancer in Portugal: a case-control study, Eur. J. Cancer Prev., 3:269–276.
42. Fero-Luzzi, A. and Serafini, M. 1995. Polyphenols in our diet: do they matter, Nutrition, 11:399–400.
43. Fitzpatrick, D.F., Hirschfield, S.L., and Coffey, R.G. 1995. Endothelium-dependent vasore-laxing activity of wine and other grape products, Am. J. Physiol., 265:H774–H778.
44. Frankel, E.N., Kanner, J., German, J.B., Parks, E., and Kinsella, J.E. 1993a. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine, Lancet, 341:454–457.
45. Frankel, E.N., Waterhouse, A.L., and Kinsella, J.E. 1993b. Inhibition of human LDL oxidation by resveratrol, Lancet, 341:1103–1104.
46. Frankel, E.N., Waterhouse, A.L., and Teissedre, P.L. 1995. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins, J. Agric. Food Chem., 43:890–894.
47. Fuhrman, B., Lavy, A., and Aviram, M. 1995. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation, Am. J. Clin. Nutr., 61:549–554.
48. Goldberg, D.M. 1995. Does wine work? Clin. Chem., 41:14–16.
49. Goldberg, D.M., Garovic-Kocic, V., Diamandis, E.P., and Pace-Asciak, C.R. 1996. Wine: does color count? Clin. Chim. Acta, 246:183–193.
50. Gorinstein, S., Zemser, M., Lichman, I., Berebi, A., Kleipfish, A., Libman, I., Trakhtenberg, S., and Caspi, A. 1987. Moderate beer consumption and the blood coagulation in patients with coronary artery disease, J. Intern. Med., 241:47–51.
51. Gryglewski, R.J., Korbut, R., Robak, J., and Swies, J. 1987. On the mechanism of antithrom-botic action of flavonoids, Biochem. Pharm., 36:317–322.
52. Gugler, R., Leschik, M., and Dengler, H.L. 1975. Disposition of quercetin in man after single oral and intravenous doses, Eur. J. Clin. Pharmacol., 9:229–234.
53. Halliwell, B. 1993. Antioxidants in wine, Lancet, 341:1538.
54. Hayek, T., Fuhrman, B., Vaya, J., Roenblat, M., Belinky, P., Coleman, R., Elis, A., and Aviram, M. 1997. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation, Arterioscler. Thromb. Vasc. Biol., 17:2744–2752.
55. Hegsted, M.D. and Ausman, L.M. 1988. Diet, alcohol and coronary heart disease in Men, J. Nutr., 118:1184–1189.
56. Hein, H.O., Suadicani, P., Gyntelbery, F. 1997. Alcohol consumption, S-LDL-cholesterol and risk of heart disease. 6-year follow-up in the Copenhagen male study, Ugeskritt Laeger, 159:4110–4416.
57. Hertog, M.G.L., Feskens, E.J.M., Hollman, P.C.H., Katan, M.B., and Kromhout, D. 1993a. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study, Lancet, 342:1007–1011.
58. Hertog, M.G.L., Feskens, E.J.M., Kromhout, D. 1997. Antioxidant flavonols and coronary heart disease risk, Lancet, 349:699.
59. Hertog, M.G., Hollman, P.C., Katan, M.B., and Kromhout, D. 1993b. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands, Nutr. Cancer, 20:21–29.
60. Hertog, M.G.L., Hollman, P.C.H., and van de Purtte, B. 1993c. Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices, J. Agric. Food Chem., 41:1242–1246.
61. Hertog, M.G.L., Kromhout, K., Aravanis, C., Blackburn, H., Buzina, R., Fidanza, F., Giampaolis, S., Jansen, A., Menotti, A.L., Nedeljkovic, S., Pekkarinen, M., Simic, B.O., Toshima, H., Feskens, E.J.M., Hollman, P.C.H., and Katan, M.B. 1995. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study, Arch. Int. Med., 155:381–386.
62. Hollman, P.C.H., Feskens, E.M.J., and Katan, M.B. 1999. Tea flavonols in cardiovascular disease and cancer epidemiology, Proc. Soc. Exp. Biol. Med., 220:198–202.
63. Hollman, P.C.H., Van der Gaag, M., and Mengelers, M.J.B. 1996. Absorption and disposition kinetics of the dietary antioxidant quercetin in man, Free Rad. Biol. Med., 21:703–707.
64. Hung, L.-M., Chen, J.-K., Huang, S.-S., Lee, R.-S., Su, M.-J. 2000. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes, Cardiovascular Res., 47:549-555.
65. Ishikawa, T., Suzukawa, M., Ito, T., Yoshida, H., Ayaori, M., Nishiwaki, M., Yonemura, A., Hara, Y., and Nakamura, H. 1997. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification, Am. J. Clin. Nutr., 66:261–266.
66. Jaeger, A., Walti, M. and Neftel, K. 1988. Side effects of flavonoids in medical practice, Prog. Clin. Biol. Res., 280:379–394.
67. Keaney, J.F., Jr. 1995. Atherosclerosis, oxidative stress, and antioxidant protection in endothe-lium-derived relaxing factor action, Prog. Cardiovasc. Dis., 38:129–154.
68. Keevil, J.G., Osman, H.E., Reed, J.D., Folts, J.D. 2000. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation, J. Nutr., 130:53–56.
69. King, A. and Young, G. 1999. Characteristics and occurrences of phenolic phytochemicals, J. Am. Diet Assoc., 99:213–218.
70. Klatsky, A.L., Armstrong, M.A., and Friedman, G.D. 1997. Red wine, white wine, liquor, beer and risk for coronary artery disease hospitalization, Am. J. Cardiol., 80:416–420.
71. Klurfeld, D.M. and Kritchevsky, D. 1981. Differential effect of alcoholic beverages on experimental atherosclerosis in rabbits, Exp. Mol. Pathol., 34:62–71.
72. Knekt, P., Jarvinen, R., Reunanen, A. and Maatela, J. 1996. Flavonoid intake and coronary mortality in Finland: a cohort story, BMJ, 312:478–481.
73. Lanningham-Foster, L., Chen, C., Chance, D.S., and Loo, G. 1995. Grape extract inhibits lipid peroxidation of human low density lipoprotein, Biol. Phar. Bull., 18:1347–1351.
74. Laughton, M.L., Halliwell, B., Evans, P., Robin, J., and Hoult, S. 1989. Antioxidant and prooxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin–dependent damage to DNA, Biochem. Pharmacol., 38:2859–2865.
75. Lavy, A., Fuhrman, B., Markel, A., Dankner, G., Amotz, A.B., Presser, D., and Aviram, M. 1994. Effect of dietary supplementation of red or white wine on human blood chemistry, hematology and coagulation: favorable effect of red wine on plasma high-density lipoprotein, Ann. Nutr. Metab., 38:287–294.
76. Law, M. and Wald, N. 1999. Why heart disease mortality is low in France: the time lag explanation, BMJ, 318:1471–1480.
77. Maiani, G., Serafini, M., Salucci, M., Axxini, E., Ferro-Luzzi, A. 1997. Application of new high-performance liquid chromatographic method for measuring selected polyphenols in human plasma, J. Chromat. B. Biomed. Sci. Appl., 692:311–317.
78. Manach, C., Morand, C., Texier, O., Agullo, G.A., Demigne, C., and Ramsey, C. 1996. Bioavailability, metabolism, and physiological impact of 4-oxo-flavonoids, Nutr. Res., 16:517–544.
79. Manach, C., Morand, C., Texier, O., Favier, M.L., Agullo, G., Demigne, C., Regerat, F., and Remesy, C. 1995. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin, J. Nutr., 125:1911–1922.
80. Manach, C., Texier, O., Morand, C., Crespy, V., Francoise R., Demigne, C., and Remesy, C. 1999. Comparison of the bioavailability of quercetin and catechin in rats, Free Rad. Biol. Med., 27:1259–1266.
81. Maxwell, S., Cruickshank, A., and Thorpe, G. 1994. Red wine and antioxidant activity in serum, Lancet, 344:193–194.
82. Meister, K. 1999. Moderate Alcohol Consumption and Health, American Council on Science and Health Report, New York.
83. Miyagi, Y., Miwa, K., and Inoue, H. 1997. Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice, Am. J. Cardiol., 80:1627–1631.
84. Muller, C.J. and Fugelsang, K.C. 1994. Take two glasses of wine and see me in the morning, Lancet, 334:1428–1429.
85. Muller, C.J. and Fugelsang, K.C. 1997. Red wine but not white: the importance of fully characterizing wines used in health studies, Am. J. Clin. Nutr., 66:447–51.
86. Nigdikar, S.V., Williams, N.R., Griffin, B.A., and Howard, A.N. 1998. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo, Am. J. Clin. Nutr., 68:258–265.
87. Nyyssonen, K., Porkkala-Sarataho, E., and Salonen, J.T. 1997. Ascorbate and urate are the oxidation in Finnish men, Atherosclerosis, 130:223–233.
88. Ohshima, H., Yoshie, Y., Auriol, S., and Gilibert, I. 1998. Antioxidant and pro-oxidant actions of flavonoids: effects on DNA damage induced by nitric oxide, peroxynitrite and nitroxyl anion, Free Rad. Biol. Med., 25:1057–1065.
89. Otero, P., Viana, M., Herrera, E., and Bonet, B. 1997. Antioxidant and prooxidant effects of ascorbic acid, dehydroascorbic acid and flavonoids on LDL submitted to different degrees of oxidation, Free Rad. Res., 27:619–626.
90. Ozturk, H.S., Kacmaz, M., Cimen, M.Y.B., and Durak, I. 1999. Red wine and black grape strengthen blood antioxidant potential, Nutr., 15:954.
91. Pace-Asciak, C.R., Hahn, S., Diamandis, E.P., Soleas, G., and Goldberg, D.M. 1995. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease, Clin. Chim. Acta, 235:207–219.
92. Pace-Asciak, C.R., Rounova, O., Hahn, S.E., Diamandis, E.P., and Goldberg, D.M. 1996. Wines and grape juices as modulators of platelet aggregation in healthy human subjects, Clin. Chim. Acta, 246:163–182.
93. Pellegrini, N., Pareti, F.I., Stabile, F., Brusamolino, A., Simonetti, P. 1996. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers, Eur. J. Clin. Nutr., 50:209–213.
94. Prior, R.L., Cao, G. 1999. Antioxdiant capacity and polyphenolic components of teas: implications for altering in vivo antioxidants status, Proc. Soc. Exp. Biol. Med., 220:255–261.
95. Rankin, S.M., de Whalley, C.V., Hoult, J.R., Jessup, W., Wilkins, G.M., Collard, J., and Leake, D.S. 1993. The modification of low density lipoprotein by the flavonoids myricetin and gossypetin, Biochem. Pharm., 45:67–75.
96. Renaud, S., De Lorgeril, M. 1992. Wine, alcohol, platelets, and the French Paradox for coronary heart disease, Lancet, 339:1523–1526.
97. Renaud, S. and Ruf, J.C. 1994. The French Paradox: vegetables or wine, Circulation, 90:3118.
98. Rice-Evans, C.A., Miller, N.J., and Paganaga, G. 1996. Structure-antioxidant activity relationships of flavonoids and phenolic acids, Free Rad. Biol. Med., 20:933–956.
99. Rifici, V.A., Stephan, E.M., Schneider, S.H., and Khachadurian, A.K. 1999. Red wine inhibits the cell-mediated oxidation of LDL and HDL, J. Am. Coll. Nutr., 18:137–143.
100. Rimm, E.B., Katan, M.B., Ascherio, A., Stampfer, M.J., and Willett, W.C. 1996. Relation between intake of flavonoids and risk of coronary heart disease in male health professionals, Ann. Int. Med., 125:384–389.
101. Rubin, E. 1993. The chemical pathogenesis of alcohol-induced tissue injury, Alcohol Health Res. Wld., 17:272–278.
102. Ruf, J.C., Berger, J.L., and Renaud, S. 1995. Platelet rebound effect of alcohol withdrawal and wine drinking in rats, Arterioscler. Thromb. Vasc. Biol., 15:140–144.
103. St.Leger A.S., Cochrane, A.L., and Moore, F. 1979. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine, Lancet, 1017–1020.
104. Salah, N., Miller, N.J., Paganaga, G., Tijburg, L., Bolwell, G.P., and Rice-Evans, C. 1995. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants, Arch. Biochem. Biophys., 322:339–349.
105. Sato, M., Maulik, G., Ray, P.S., Bagchi, D., Das, D.K. 1999. Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury, J. Mol. Cell. Cardiol., 31:1289–1297.
106. Sato, M., Ray, P.S., Maulik, G., Maulik, N., Engelman, R.M., Bertelli, A.E., Bertelli, A., and Das, D.K. 2000. Myocardial protection with red wine extract, J. Cardio. Pharm., 35:263–268.
107. Scalbert, A. and Williamson, G. 2000. Dietary intake and bioavailability of polyphenols, J. Nutr., 130:2073S–2085S.
108. Schneider, J., Kaffarnik, H., and Steinmetz, A. 1996. Alcohol, lipid metabolism and coronary heart disease, Herz, 21:217–226.
109. Seigneur, M., Bonnet, J., Dorian, B., Benchimol, D., Drouiller, F., Gouverneur, G., Larrue, J., Crockett, R., Boisseau, M.R., Ribereau-Gayon, P., and Bricaud, H. 1990. Effect of the consumption of alcohol, white wine, and red wine on platelet function and serum lipid, J. Appl. Cardiol., 5:215–222.
110. Serafini, M., Maiani, G., and Ferro-Luzzi, A. 1998. Alcohol-free red wine enhances plasma antioxidant capacity in humans, J. Nutr., 128:1003–1007.
111. Sharp, D. 1993. When wine is red, Lancet, 341:27–28.
112. Sharpe, P.C., McGrath, L.T., McClean, E., Young, I.S., and Archbold, G.P.R. 1995. Effect of red wine consumption on lipoprotein (a) and other risk factors for atherosclerosis, Q. J. Med., 88:101–108.
113. Skibola, C.F. and Smith, M.T. 2000. Potential health impacts of excessive flavonoid intake, Free Rad. Biol. Med., 29:375–383.
114. Soleas, G.J. and Goldberg, D.M. 1999. Analysis of antioxidant wine polyphenols by gas chro-matography-mass spectrometry, Mthd. Enzymol., 299:137–151.
115. Stadler, R.H., Markovic, J., and Turesky, R.J. 1995. In vitro anti-and pro-oxidative effects of natural polyphenols, Biol. Trace Element Res., 47:299–305.
116. Stein, J.H., Keevil, J.G., Wiebe, D.A., Aeschilmann, S., and Folts, J.D. 1999. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease, Circ., 100:1050–1055.
117. Struck, M., Watkins, T., Tomeo, A., Halley, J., and Bierenbaum, M. 1994. Effects of red and white wine on serum lipids, platelet aggregation, oxidation products and antioxidants: a preliminary report, Nutr. Rev., 14:1811–1819.
118. Sugihara, N., Arakawa, T., Ohnishi, M., and Furuno, K. 1999. Anti-and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with α-linolenic acid, Free Rad. Biol. Med., 27:1313–1323.
119. Troup, C.J., Hutton, D.R., Hewitt, D.G., and Hunter, C.R. 1994. Free radicals in red wine, but not in white? Free Rad. Res., 20:63–68.
120. Ueno, I., Nakano, N., and Hirono, I. 1983. Metabolic fate of [14C] quercetin in the ACI rat, Jpn. J. Exp. Med., 53:41–50.
121. Ursini, F., Tubaro, F., Rong, J., and Sevanian, A. 1999. Optimization of nutrition: polyphenols and vascular protection, Nutr. Rev., 57:241–249.
122. van het Hof, L.H., Kivits, G.A.A., Westtrate, J.A., and Tijburg, L.B.M. 1998. Bioavailability of catechins from tea: the effect of milk, Eur. J. Clin. Nutr., 52:356–359.
123. Whitehead, T.P., Robinson, D., Allaway, S., Syms, J., and Hale, A. 1995. Effect of red wine ingestion on the antioxidant capacity of serum, Clin. Chem., 41:32–35.
124. Wilson, T., Knight, T.J., Beitz, D.C., Lewis, D.S., and Engen, R.L. 1996. Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits, Life Sciences, 59:15–21.
125. Xu, R., Yokoyama, W.H., Irving, D., Rein, D., Walzem, R.L., and German, J.B. 1998. Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters, Atherosclerosis, 137:29–36.
126. Yamakoshi, J., Kataoka, S., Koga, T., and Ariga, T. 1999. Proanthocyanidin–rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits, Atherosclerosis, 142:139–149.
127. Zakhari, S. and Gordis, E. 1999. Moderate drinking and cardiovascular health, Proc. Assoc. Am. Phys., 111:148–158.